Revisiting Proteasome Inhibitors: Molecular Underpinnings of Their Development, Mechanisms of Resistance and Strategies to Overcome Anti-Cancer Drug Resistance

Proteasome inhibitors have shown relevant clinical activity in several hematological malignancies, namely in multiple myeloma and mantle cell lymphoma, improving patient outcomes such as survival and quality of life, when compared with other therapies. However, initial response to the therapy is a c...

Descripción completa

Detalles Bibliográficos
Autores principales: Leonardo-Sousa, Carlota, Carvalho, Andreia Neves, Guedes, Romina A., Fernandes, Pedro M. P., Aniceto, Natália, Salvador, Jorge A. R., Gama, Maria João, Guedes, Rita C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000344/
https://www.ncbi.nlm.nih.gov/pubmed/35408601
http://dx.doi.org/10.3390/molecules27072201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000344/
https://www.ncbi.nlm.nih.gov/pubmed/35408601
http://dx.doi.org/10.3390/molecules27072201

Ejemplares similares